Please wait a minute...

中国生物工程杂志

CHINA BIOTECHNOLOGY
中国生物工程杂志  2010, Vol. 30 Issue (04): 1-7    
技术与方法     
抗EGFRvIII噬菌体抗体库的构建和筛选
周敏,石必枝,顾健人,李宗海**
上海交通大学医学院上海市肿瘤研究所癌基因及相关基因国家重点实验室 上海 200032
Construction and Screening of Phage Antibody Libraries Against Epidermal Growth Factor Receptor Variant Type III
ZHOU Min,SHI Bi-zhi,GU Jian-ren,LI Zong-hai
State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Medical School of Shanghai Jiaotong University, Shanghai 200032, China
 全文: PDF(690 KB)   HTML
摘要:

目的:应用噬菌体展示技术筛选针对表皮生长因子受体突变体Ш (epidermal growth factor receptor variant type Ⅲ, EGFRvIII)的单链抗体 (single chain Fv, scFv)。方法:利用原核表达纯化的人EGFRvIIIex蛋白和高表达EGFRvIIIex的小鼠成纤维细胞系NIH3T3免疫小鼠,扩增VH和VL片段并拼装成scFv 基因,连接至噬菌粒pCANTAB 5E,电击转化Hpd3cells,构建噬菌体单链抗体库,并进行3轮富集筛选。在第4轮筛选时,采用了降低抗原浓度的方法。然后将筛选得到的阳性克隆测序分析,转化E.coli HB2151,IPTG 诱导可溶性scFv 的表达。结果:构建了库容为7.9×107 的噬菌体单链抗体库。经过第4轮低浓度抗原筛选,得到了较高亲和力的克隆。取单个阳性克隆测序分析结果表明,该抗EGFRvIII scFv 基因序列长807 bp,编码268个氨基酸。IPTG诱导后表达的可溶性scFv 可分别与纯化的EGFRvIIIex抗原以及细胞表面的EGFRvIIIex结合。结论:利用噬菌体抗体库筛选得到了高亲和力的抗EGFRvIII scFv,为开发针对EGFRvIII的抗体药物提供了靶向载体分子。

关键词: 表皮生长因子受体突变体Ш噬菌体抗体库单链抗体    
Abstract:

Objective: To construct a phage display library of single chain variable fragment (scFv) antibodies and to screen a scFv antibody against epidermal growth factor receptor variant type III (EGFRvIII). Method: Balb/c mice were immunized by recombinant EGFRvIIIex and NIH3T3/EGFRvIIIex cell line. Genes of variable heavy (VH) and variable light (VL) chains of antibodies were prepared by RT-PCR from the splenic cells of immunized mice and further artificially joined with a flexible peptide linker, then ligated into the phagemid vector pCANTAB 5E. The phagemides containing scFv were transformed into electrocompetent Hpd3cells. The recombinant phages were enriched through 3 rounds of affinity panning and the anti-EGFRvIII phage scFv clones were identified by ELISA. The fourth round of panning performed at a higher stringency of selection, which used a capture concentration of 0.5μg or 0.05μg. After identified by ELISA, one positive clone was sequenced and transfected into E.coli HB2151 cells to express. Result: A phage display library with a complexity of approximately 7.9×107 was constructed. After the fourth round of panning performed at a increasing stringency of selection, higher affinity clones were obtained. Sequencing analysis showed that the anti-EGFRvIII scFv was 807 base pairs coding 268 amino acids. The soluble scFv exhibited the binding activity to purified recombinant EGFRvIIIex protein and EGFRvIII overexpression cell line. Conclusion: The successful preparation of anti-EGFRvIII scFv will provide an EGFRvIII targeted molecule for the development of antibody-based drugs.

Key words: Epidermal growth factor receptor variant type III    Phage antibody library    Single chain antibody
收稿日期: 2009-12-22 出版日期: 2010-04-29
基金资助:

国家“863”计划(2007AA021203)、上海市青年科技启明星计划(07QA14046)资助项目

通讯作者: 李宗海     E-mail: zonghaili@gmail.com
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  
周敏
石必枝
顾健人
李宗海

引用本文:

周敏 石必枝 顾健人 李宗海. 抗EGFRvIII噬菌体抗体库的构建和筛选[J]. 中国生物工程杂志, 2010, 30(04): 1-7.

ZHOU Min, DAN Bi-Qi, GU Jian-Ren, LI Zong-Hai. Construction and Screening of Phage Antibody Libraries Against Epidermal Growth Factor Receptor Variant Type III. China Biotechnology, 2010, 30(04): 1-7.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/        https://manu60.magtech.com.cn/biotech/CN/Y2010/V30/I04/1

[1] Kuan C T, Wikstrand, C J, Bigner, D D.EGF mutant receptor vIII as a molecular target in cancer therapy. Endocr Relat Cancer, 2001, 8(2): 8396. 
[2] Pedersen M W, Meltorn M, Damstrup L, et al. The type III epidermal growth factor receptor mutation. Biological significance and potential target for anticancer therapy. Ann Oncol, 2001, 12(6): 745760. 
[3] Fukai J, Nishio K, Itakura T, et al. Antitumor activity of cetuximab against malignant glioma cells overexpressing EGFR deletion mutant variant III. Cancer Sci, 2008, 99(10): 20622069. 
[4] Wikstrand C J, Hale L P, Batra S K, et al. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res, 1995, 55(14): 31403148. 
[5] Li D, Ji H, Zaghlul S, et al. Therapeutic antiEGFR antibody 806 generates responses in murine de novo EGFR mutantdependent lung carcinomas. J Clin Invest, 2007, 117(2): 346352. 
[6] Azzazy H M, Highsmith W E. Phage display technology: clinical applications and recent innovations. Clin Biochem, 2002, 35(6): 425445. 
[7] 王华茂. 抗EGFRvIII单克隆抗体制备及其在肝癌治疗中的应用. 上海:复旦大学医学院,2009. Wang H M. Epidermal Growth Factor Receptor vIII antibody development and application in hepatocellular carcinoma therapy. Shanghai:Shanghai Medical College of Fudan University,2009. 
[8] 江秀玲,毕富勇,王华茂,等. 稳定表达EGFRvIIIex的NIH3T3细胞株的建立及其免疫原性分析. 细胞与分子免疫学杂志,2007,23(7):612615. Jiang X L, Bi F Y, Wang H M, et al. Chinese Journal of Cellular and Molecular Immunology,2007,23(7):612615. 
[9] Shi B Z, Wang H M, Guo S R, et al. Protein IIIbased singlechain antibody phage display using bacterial cells bearing an additional genome of a geneIIIlacking helper phage. BioTechniques, 2007, 42(6): 760765. 
[10]Hudson P J, Souriau C. Engineered antibodies. Nat Med, 2003, 9(1): 129134.

[1] 李彤彤,宋彩玲,杨凯越,王文静,陈慧宇,刘明. 抗犬细小病毒VP2蛋白单链抗体的制备与中和活性研究 *[J]. 中国生物工程杂志, 2020, 40(4): 10-16.
[2] 安明晖,田文,韩晓旭,尚红. 表达HIV单链抗体的重组乳酸杆菌的构建及表型分析 *[J]. 中国生物工程杂志, 2019, 39(10): 1-8.
[3] 高鑫,韦攀健,闫卓红,易玲,王小珏,杨斌,张洪涛. 一株针对人EGFR的单链抗体克隆与哺乳细胞表达 *[J]. 中国生物工程杂志, 2018, 38(5): 73-78.
[4] 赵荣,陈含宇,黄春,章晓联,潘勤. 靶向B细胞并特异结合其分泌IL-10的重组融合蛋白的构建、表达和初步鉴定 *[J]. 中国生物工程杂志, 2018, 38(2): 1-6.
[5] 庞倩,陈晶,王小红,王佳. 基于噬菌体展示技术抗黄曲霉毒素B1单链抗体的筛选及其蛋白结构分析 *[J]. 中国生物工程杂志, 2018, 38(12): 41-48.
[6] 王冬冬, 张国利, 岳玉环, 吴广谋, 田园, 刘雨玲, 吉元刚, 王金鹏, 李建, 潘荣荣, 马洪圆. 抗A型产气荚膜梭菌α毒素全人源双价单链抗体的构建、表达及其活性的初步研究[J]. 中国生物工程杂志, 2017, 37(4): 18-25.
[7] 温杰, 宋琳琳, 张莹, 王荷, 何金生, 洪涛. 稳定表达Aβ特异性单链抗体的哺乳动物细胞株构建和功能研究[J]. 中国生物工程杂志, 2017, 37(2): 1-7.
[8] 陈华新, 武静, 赵瑾, 姜鹏. 抗人AFP单链抗体与藻胆蛋白融合蛋白的构建、表达与活性分析[J]. 中国生物工程杂志, 2016, 36(5): 74-80.
[9] 代云见, 张勇侠, 何勇智, 丛聪, 张涛, 王明蓉. 技术与方法Anti-IgE单链抗体纯化工艺研究及活性鉴定[J]. 中国生物工程杂志, 2015, 35(12): 51-57.
[10] 王报贵, 武晓丽, 董素琴, 甘敏, 陈星星, 陈飞, 明星, 徐锋. 抗肠炎沙门氏菌单链抗体制备及其特异性分析[J]. 中国生物工程杂志, 2013, 33(5): 62-67.
[11] 陈继军, 毛晓燕, 乔玉玲, 毕司英. 抗狂犬病病毒单链抗体的筛选及鉴定[J]. 中国生物工程杂志, 2013, 33(11): 27-31.
[12] 刘启刚, 代云见, 张勇侠, 王保成, 王明蓉. 抗IgE单链抗体在大肠杆菌中可溶性高效表达条件的研究[J]. 中国生物工程杂志, 2012, 32(11): 23-28.
[13] 刘启刚, 代云见, 张勇侠, 王保成, 王明蓉. 抗IgE单链抗体在大肠杆菌中可溶性高效表达条件的研究[J]. 中国生物工程杂志, 2012, 32(11): 23-28.
[14] 王晓娜, 米志强, 安小平, 李建彬, 范华昊, 张文慧, 张博, 黄勇, 周丽君, 童贻刚. 从大容量噬菌体抗体库中筛选抗Acr蛋白人源单链抗体[J]. 中国生物工程杂志, 2012, 32(09): 22-27.
[15] 代鹏, 周广青, 林密, 冯霞, 马军武, 张晓霞. 利用核糖体展示技术筛选口蹄疫病毒 单链抗体基因[J]. 中国生物工程杂志, 2012, 32(07): 95-101.